Sanjeev Thohan is a highly accomplished research scientist specializing in pharmacology and toxicology. With a track record of developing and advancing 36 small molecule compounds through discovery to IND and active clinical development, Sanjeev has a wealth of experience in therapeutic areas including oncology, cardiovascular and metabolic diseases, and antimicrobial and antiviral treatments. He has worked with reputable organizations such as Walter Reed Army Institute for Research, Covance Laboratories, AstraZeneca, Viropharma, and Exelixis, and he is currently the Vice President of Nonclinical Development at Kinnate Biopharma in San Diego.

Sanjeev is a distinguished scholar who holds both MS and PhD degrees in pharmacology and toxicology, with concentrations in drug metabolism mechanisms, bioactivation pathways, and systems toxicology. He is also a renowned speaker and has participated in numerous scientific groups as an expert in preclinical safety/mechanistic toxicology, ADME-PKPD relationships, and translational sciences.

As the founder of SARx Consulting, Sanjeev has led teams to evaluate strategic critical pathway development, implementation and execution to provide data front-loading and reduction in time to IND. He has also provided metabolic pathway elucidation and structural (SAR) feedback to medicinal chemistry for additional iterations based on biological data streams.

Sanjeev has served on the advisory boards of several start-ups and actively contributes to various national/international scientific societies. His expertise and versatility make him a valuable asset to any organization looking to advance scientific research and develop innovative therapies.